Croma submits toxin for EU approval
Pharmaceutical company Croma Pharma has submitted its botulinum toxin drug file to the German Federal Institute for Drugs and Medical Devices (BfArM), for approval for the treatment of glabellar lines in the EU.
Pharmaceutical company Croma Pharma has submitted its botulinum toxin drug file to the German Federal Institute for Drugs and Medical Devices (BfArM), for approval for the treatment of glabellar lines in the EU.
Medical aesthetic company Evolus Inc has announced that the European Commission (EC) has approved the marketing of Nuceiva prabotulinumtoxinA (branded Jeuveau in the US and known in other markets as Nabota).